Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-70.54	8.11	27.51
Graham Fair Price	388.87	470488.52	96240.63
PEG	-99.80	< 0.005	0.23
Price/Book	-5.73	0.20	0.21
Price/Cash Flow	-99.64	0.93	253.90
Prices/Earnings	-95.73	1.09	-25.45
Price/Sales	-14.57	0.18	0.21
Price/FCF	-99.64	0.93	253.90
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	69.28	0.09	0.05
Operating Margin	1416.49	0.05	< 0.005
ROA	2049.32	0.02	< 0.005
ROE	< 0.005	0.05	2107.01
ROIC	< 0.005	0.03	21824.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	133.30
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.85	16.41	1820.27
EPS QOQ	-1.13	23.97	2023.90
FCF QOQ	1.02	268.09	26182.21
Revenue QOQ	0.60	0.15	-75.41
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.42	2.78	14.88
Days Sales Outstanding (DSO)	42.69	34.11	-20.09
Inventory Turnover	37.19	32.38	-12.95
Debt/Capitalization	0.42	0.41	-1.84
Quick Ratio	1.42	1.39	-2.31
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	443054.33	461047.19	4.06
Cash	280867.82	401162.66	42.83
Capex	-9321.59	-9105.62	2.32
Free Cash Flow	372.59	100261.59	26809.10
Revenue	446549.51	512732.52	14.82
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.46	1.43	-2.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.88	5.56	-72.05
Naive Interpretation	Member

06 - Financial Health · Weak

Rating